跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
RIVA-PYRIDOSTIGMINE - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
RIVA-PYRIDOSTIGMINE
Authorized
STANDARD
RIVA-PYRIDOSTIGMINE
laboratoire riva inc.
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
c7ad62552df777c4
Company
laboratoire riva inc.
Type
Standard
Approval Details
Approval Id
c7ad62552df777c4
Drug Approval Canada Name
RIVA-PYRIDOSTIGMINE
Product Name
RIVA-PYRIDOSTIGMINE
Status
Marketed
Status Date
2020-08-24
Original Market Date
2020-08-24
Din
02495643
Drug Class
Human
Dosage Form
Tablet
Route Of Administration
Oral
Schedule
Prescription
Ahfs
12:04.00
Atc Original
N07AA02 PYRIDOSTIGMINE
Atc Name
n 07 aa 02
Aig Number
0107514003
Company Name
laboratoire riva inc.
Company Address
660 Boul. Industriel, Blainville, Quebec, Canada, J7C 3V4
Active Ingredients
PYRIDOSTIGMINE BROMIDE
60 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
c7ad62552df777c4
Type
Standard
Back to Health Canada Approvals